Pediatric patients with chronic heart failure
Conditions
Interventions
Control Group:Traditional Follow-up Management Model
Intervention Group:Management of the Smart Platform at the Pediatric Patient Follow-up Center, Beijing Children's Hospital
Sponsors
Beijing Childrens Hospital,Capital Medical University
Eligibility
Sex/Gender
All
Age
No minimum to 18 Years
Inclusion criteria
Inclusion criteria: 1.Pediatric patients with heart failure admitted to the Department of Cardiology, Beijing Children's Hospital Affiliated to Capital Medical University; 2.Aged under 18 years; 3.Meet the diagnostic criteria for "chronic heart failure" specified in the Chinese Guidelines for Diagnosis and Treatment of Pediatric Heart Failure (2020 Edition) and international guidelines such as the ESC Consensus on the Management of Pediatric Heart Failure—namely, presenting clinical manifestations of heart failure including dyspnea, feeding difficulties, growth retardation, edema, pulmonary rales, etc.; confirmed by echocardiography to have an LVEF < 50% (systolic heart failure) or diastolic dysfunction, with a disease duration of = 3 months (excluding acute heart failure or transient cardiac dysfunction); 4.With complete demographic characteristics, clinical data, laboratory test results, and follow-up data available; 5.Whose legal guardian (or the child themselves, if appropriate) voluntarily signs the informed consent form and commits to completing 6 months of follow-up, including use of the smart platform, regular re-examinations, and data submission—will be included in the study.
Exclusion criteria
Exclusion criteria: 1.Patients will be excluded if they have comorbidities such as end-stage liver and renal failure, malignant tumors, severe infections (e.g., sepsis), or neurological disorders (e.g., cerebral palsy) that are expected to independently affect prognosis; 2.Have incomplete medical records or missing data; 3.Lost to follow-up after treatment; 4Have participated in other similar heart failure management intervention studies; 5.If the patient or their guardian refuses to sign the informed consent form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MACE includes all-cause death, non-fatal myocardial infarction, non-fatal stroke, severe arrhythmias, readmission due to heart failure, , and cardiovascular-related surgery/interventional therapy.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Left ventricular ejection fraction;Left ventricular end-diastolic diameter;Quality of Life Score;NYHA/ROSS Classification of Cardiac Function;Six-Minute Walk ; | — |
Countries
China
Contacts
Public ContactYanyan Xiao
Beijing Childrens Hospital,Capital Medical University
Outcome results
None listed